Updated: October 22, 2026
Russian researchers have identified a new biologically active compound in sea buckthorn leaves — casuarictin, which exhibits a pronounced antitumor effect. Laboratory studies have demonstrated that this natural component can inhibit the growth of cancer cells, making it a potential candidate for developing drugs against oncological diseases. The discovery was made at Russian scientific centers in 2026 and has attracted significant attention from the research community due to its promising medical applications.
Origin and Composition of Casuarictin
Casuarictin is a flavonoid compound found in the leaves of sea buckthorn, a plant widely distributed across Russia and the CIS countries. Sea buckthorn is well-known for its richness in biologically active substances, including vitamins, carotenoids, and antioxidants, which have long been used in folk and scientific medicine. Research into the composition of sea buckthorn leaves, conducted in 2026 by scientists from the Biochemistry Institute of the Russian Academy of Sciences, identified casuarictin as a new element with unique properties.
Antitumor Properties and Laboratory Testing
These results were obtained at the Petrov Oncology Institute in St. Petersburg, where new anticancer drugs are being developed. The inhibitory effect is enhanced when casuarictin is combined with other biologically active components of sea buckthorn, which may form the basis of a comprehensive therapy with minimal side effects.
Potential for Pharmaceutical Development
The discovery of casuarictin as a powerful tumor cell inhibitor has laid the groundwork for the development of new medications based on it. In 2026, several Russian pharmaceutical companies, including PharmBioTech from Moscow, expressed interest in funding clinical trials and creating extracts with high casuarictin content.
Significance for Russian Agriculture and Economy
Prospects and Next Steps in Research
The next phase of scientific work will involve preclinical studies on animal models and developing methods to stabilize casuarictin in pharmaceutical formulations. In 2026, research teams plan to begin trials on laboratory mice to assess toxicity and efficacy against various tumor types.
Simultaneously, efforts are underway to find synthetic analogs of casuarictin that may possess improved pharmacological properties. These projects are conducted in collaboration with universities in Moscow and Novosibirsk, expanding the research base and increasing the likelihood of developing competitive drugs.
Conclusion: The discovery of casuarictin in sea buckthorn leaves opens new prospects in cancer treatment and stimulates growth in Russia’s pharmaceutical and agricultural sectors.
Sources
- barnaul.bezformata.com — “Scientists Discovered Anticancer Substance in Leaves”
- kp.ru — “Russian Scientists Found a Compound in Sea Buckthorn”
- podmoskovye.bezformata.com — “‘Prickly Shield Against Tumors’: Sea Buckthorn Leaves Contain…”
- amic.ru — “Scientists Discovered an Anticancer Substance in…”
- cyberleninka.ru — “Sea Buckthorn: Medicinal and Preventive Remedy”